Fecal Transplant Durable in IBS; Growth Hormone for NAFLD? Drug Use and DAA Activity
(MedPage Today) -- Fecal microbiota transplant for inflammatory bowel syndrome (IBS) led to high response rates versus placebo and showed durable benefit out to 3 years, a trial from Norway showed. (Gastroenterology)
Use of growth hormone in non...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Gastroenterology | Hormones | Non-alcoholic Fatty Liver Diseases (NAFLD) | Norway Health | Transplants